Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01KMR
|
|||
Former ID |
DCL000895
|
|||
Drug Name |
Neramexane
|
|||
Synonyms |
Neramexane [INN]; Mrz 2579; MRZ 2-579; 1,3,3,5,5-Pentamethylcyclohexanamine; 1,3,3,5,5-pentamethylcyclohexan-1-amine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Cancer related pain [ICD-11: MG30; ICD-10: R52.1, R52.2] | Phase 2 | [1] | |
Therapeutic Class |
Analgesics
|
|||
Company |
Merz Pharmaceuticals GmbH
|
|||
Structure |
Download2D MOL |
|||
Formula |
C11H23N
|
|||
Canonical SMILES |
CC1(CC(CC(C1)(C)N)(C)C)C
|
|||
InChI |
1S/C11H23N/c1-9(2)6-10(3,4)8-11(5,12)7-9/h6-8,12H2,1-5H3
|
|||
InChIKey |
OGZQTTHDGQBLBT-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 219810-59-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Antagonist | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Emerging analgesics in cancer pain management. Expert Opin Emerg Drugs. 2005 Feb;10(1):151-71. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.